Profil
Thomas L.
Long is currently the VP-Manufacturing & Technical Operations at PLx Pharma, Inc. He previously worked as the SVP & General Manager-Manufacturing Operations at Adams Respiratory Therapeutics, Inc.
Postes actifs de Thomas L. Long
| Sociétés | Poste | Début |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Corporate Officer/Principal | 19/09/2017 |
Anciens postes connus de Thomas L. Long
| Sociétés | Poste | Fin |
|---|---|---|
Adams Respiratory Therapeutics, Inc.
 Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Health Technology |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of a technology platform for approved drugs. It offers the PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Dover, DE. | Health Technology |
